Balida, Ruben .
HRN: 23-30-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
CEFTRIAXONE 1G (VIAL)
07/10/2023
07/16/2023
IVT
2g
Od
Pleural Effusio
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes